Advanced BioScience Laboratories, Inc.
Advanced BioScience Laboratories, Inc. (ABL) is a global biomedical contract research and manufacturing organization dedicated to advancing vaccines, therapeutics, and other biologic products. ABL leverages its expertise in product development, GMP manufacturing, and immunological testing to support the development of candidate vaccines and therapeutics through preclinical and clinical stages. The company is involved in producing and testing oncolytic viruses, gene therapies, immunotherapies, viral vaccines, and recombinant protein vaccines.
Advanced BioScience Laboratories, Inc.
9800 Medical Center Drive, Building D, Rockville, MD 20850 USA
What We Do
ABL provides a range of ELISA kits for various applications in research and diagnostics.
ABL offers comprehensive biomanufacturing services including virus manufacturing, process development, aseptic fill finish, cell & virus banking, and biologics and QC testing.
ABL partners with government entities to advance research and development in the field of biomanufacturing and therapeutics.
Application Area
Regenerative Medicine
Digital Health Technologies
News & Updates
ABL's U.S. location is accredited for Good Clinical Laboratory Practices (GCLP) standards.
ABL Lyon's site is accredited for ISO 9001.
ABL's U.S. location is accredited for ISO 9001.
ABL Europe's Strasbourg site received a Certificate of GMP Compliance for Human Investigational Medicinal Products: Aseptic Filling, Gene Therapy Product Manufacturing, and Secondary Packaging.
ABL Europe's Strasbourg site received a Certificate of GMP Compliance for Quality Control Testing.
ABL Lyon attended the 13th Congress of ECCO in Vienna, Austria, from February 14-17, 2018.